| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს ჰელიოს ფარმა | შპს მედ ფარმასი გრუპი | შპს მედიმექსი |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾5.0m₾0 | ₾3.4m₾0 | ₾1.8m₾0 | ₾1.3m₾2.0m |
| Revenue growth | — | — | — | -35.1% |
| Profitability | ||||
| EBITDA | -₾1.5m₾0 | ₾1.5m₾0 | ||
| ₾269k₾0 |
| ₾470k₾1.1m |
| EBITDA margin | -29.7% | 45.3% | 14.8% | 36.2%57.4% |
| Net profit | -₾1.5m₾0 | ₾1.3m₾0 | ₾229k₾0 | ₾8.8m-₾580k |
| Net margin | -29.7% | 38.5% | 12.5% | 675.1%-28.9% |
| Balance sheet | ||||
| Total assets | ₾649k₾2.4m | ₾2.1m₾1.3m | ₾1.7m₾1.5m | ₾11.5m₾16.8m |
| Total equity | -₾1.1m₾357k | ₾1.7m₾1.2m | ₾1.3m₾1.1m | ₾11.2m₾208k |
| ROE | —0.0% | 77.6%0.0% | 17.8%0.0% | 78.2%-279.0% |